Outcomes in B non-Hodgkin lymphoma (B-NHL) patients undergonig autologous stem cell transplant (ASCT) in the Rituximab era: risk of hypogammaglobulinaemia and impact on post-ASCT infections

被引：0
|
作者：
Sola Soto, M. [1 ]
Serna Munoz, M. J. [1 ]
Munoz Ballester, J. [1 ]
Lopez Matencio, P. Iniesta [1 ]
Sanchez Blanco, J. J. [1 ]
Castilla Llorente, C. [1 ]
De Arriba de La Fuente, F. [1 ]
Garcia Malo, M. D. [1 ]
Perez Ceballos, E. [1 ]
Lopez Godino, O. [1 ]
Heras, I. [1 ]
Vicente Garcia, V. [1 ]
机构：
[1] Hosp Morales Meseguer, Hematol, Murcia, Spain
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P727
引用
收藏
页码：S502 / S503
页数：2
相关论文
共 50 条
  • [1] High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era
    Ban-Hoefen, Makiko
    Friedberg, Jonathan W.
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane L.
    Young, Faith
    Fisher, Richard I.
    Constine, Louis
    Becker, Michael
    Phillips, Gordon L., II
    BLOOD, 2010, 116 (21) : 992 - 992
  • [2] Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
    Ip, Andrew
    Switchenko, Jeffrey M.
    Graiser, Michael
    Koff, Jean
    Gupta, Vikas
    Lechowicz, MaryJo
    Al-Kadhimi, Zaid
    Nooka, Ajay
    Kaufman, Jonathan
    Lonial, Sagar
    Waller, Edmund K.
    Langston, Amelia A.
    Flowers, Christopher
    Cohen, Jonathon B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S135 - S136
  • [3] Impact of intensive stem cell mobilization therapy on outcomes following autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)
    Damon, L. E.
    Damon, L.
    Kaplan, L.
    Martin, T., III
    Linker, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Incorporating target immunotherapy into standard conditioning regimen prior to autologous stem cell transplantaion (ASCT) improves the, transplant outcome for pateints with relapsed/refractroy B cell non-Hodgkin lymphoma (B-NHL)
    Farhat, Mohamed I.
    Karmali, Reem
    Gregory, Stephanie A.
    Venugopal, Parameswaran
    Kassar, Mohamad
    Shah, Neel
    Brooks, Terrance
    Fung, Henry C.
    BLOOD, 2007, 110 (11) : 568A - 568A
  • [5] Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)
    Jagadeesh, Deepa
    Rybicki, Lisa
    Abounader, Lonna
    Liu, Hein
    Dean, Robert M.
    Hill, Brian T.
    Sobecks, Ronald M.
    Gerds, Aaron
    Hamilton, Betty Ky
    Pohlman, Brad
    Kalaycio, Matt E.
    Bolwell, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S224 - S225
  • [6] Experience with yttrium 90 ibritumomab tiuxetan after autologous stem cell transplant (ASCT) in patients with non-Hodgkin's lymphoma (NHL).
    Joyce, J
    Schuster, MW
    McCook, B
    Torok, F
    Avril, N
    Vidnovic, N
    Jacobs, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [7] Pulmonary mortality after high-dose oral busulfan and autologous stem cell transplant (ASCT) in patients with non-Hodgkin lymphoma (NHL).
    Kalaycio, M
    Pohlman, B
    Rybicki, L
    Sobecks, R
    Kuczkowski, E
    Andresen, S
    Brown, S
    Bolwell, B
    BLOOD, 2005, 106 (11) : 501A - 502A
  • [8] HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for B Cell Non Hodgkin Lymphoma (NHL)
    Krishnan, Amrrra
    Zaia, John
    Alvarnas, Joseph
    Kogut, Neil
    Spielberger, Ricardo
    Wardlow, Michelle
    Tsai, Nicole
    Paris, Tanya
    Forman, Stephen J.
    BLOOD, 2008, 112 (11) : 760 - 761
  • [9] Late relapses following autologous hematopoietic stem cell (ASCT) transplantation for non-Hodgkin's lymphoma (NHL).
    Bierman, PJ
    Vose, JM
    Lynch, JC
    Bociek, RG
    Morris, ME
    Armitage, JO
    BLOOD, 1999, 94 (10) : 610A - 610A
  • [10] HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)
    Krishnan, Amrita
    Palmer, Joycelynne M.
    Zaia, John A.
    Tsai, Ni-Chun
    Alvarnas, Joseph
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1302 - 1308
12345